During the past decade, Coltea Clinical Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 12 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coltea Clinical Hospital" #1 sponsor was "Amgen" with 5 trials, followed by "AOP Orphan Pharmaceuticals AG" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "NanoCarrier Co., Ltd." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coltea Clinical Hospital" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Coltea Clinical Hospital" are "Polycythemia Vera" (2 trials), "Relapsed Multiple Myeloma" (2 trials), "Abdominal Surgery" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Anaplastic Large-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Coltea Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Coltea Clinical Hospital" are "Drug" (28 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lenalidomide" (4 trials), "Carfilzomib" (3 trials), "Dexamethasone" (3 trials) and "Avelumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Coltea Clinical Hospital" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Coltea Clinical Hospital". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Coltea Clinical Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Coltea Clinical Hospital, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Coltea Clinical Hospital has several departments that took part in Clinical trials: "Spitalul Clinic Coltea; Clinica de Hematologie" - 7 trials